Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for IQV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 558.00M
March 31, 2026 618.00M
December 31, 2025 735.00M
September 30, 2025 908.00M
June 30, 2025 443.00M
March 31, 2025 568.00M
December 31, 2024 885.00M
September 30, 2024 721.00M
June 30, 2024 588.00M
March 31, 2024 522.00M
December 31, 2023 747.00M
September 30, 2023 583.00M
June 30, 2023 402.00M
March 31, 2023 417.00M
December 31, 2022 560.00M
September 30, 2022 863.00M
June 30, 2022 329.00M
March 31, 2022 508.00M
December 31, 2021 692.00M
September 30, 2021 844.00M
June 30, 2021 539.00M
March 31, 2021 867.00M
December 31, 2020 750.00M
September 30, 2020 574.00M
June 30, 2020 472.00M
Date Value
March 31, 2020 163.00M
December 31, 2019 583.00M
September 30, 2019 330.00M
June 30, 2019 391.00M
March 31, 2019 113.00M
December 31, 2018 417.00M
September 30, 2018 344.00M
June 30, 2018 311.00M
March 31, 2018 182.00M
December 31, 2017 233.00M
September 30, 2017 436.00M
June 30, 2017 245.00M
March 31, 2017 56.00M
December 31, 2016 447.05M
September 30, 2016 260.22M
June 30, 2016 40.62M
March 31, 2016 112.11M
December 31, 2015 206.32M
September 30, 2015 282.95M
June 30, 2015 50.78M
March 31, 2015 -64.35M
December 31, 2014 255.96M
September 30, 2014 137.10M
June 30, 2014 67.13M
March 31, 2014 -28.44M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Medpace Holdings, Inc. 162.01M
Charles River Laboratories International, Inc. 179.72M
Moderna, Inc. -526.00M
Fortrea Holdings, Inc. 28.90M
OmniAb, Inc. 2.679M